We are live on ! Find out more
WGSWW

GeneDx Holdings Warrant

Delisted

WGSWW was delisted on the 21st of July, 2026.

21 hedge funds and large institutions have $46.1K invested in GeneDx Holdings Warrant in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

2.74% less ownership

Funds ownership: 20.05%17.31% (-2.7%)

5% less funds holding

Funds holding: 2221 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

70% less capital invested

Capital invested by funds: $154K → $46.1K (-$108K)

Holders
21
Holders Change
-1
Holders Change %
-4.55%
% of All Funds
0.31%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
4
Reduced
1
Closed
2
Calls
$5K
Puts
Net Calls
+$5K
Net Calls Change
-$11K

WGSWW Hedge Fund Activity: Q4 2023 in Review

21 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings Warrant (WGSWW) for Q4 2023, worth a combined $46.1K — down 70% from $154K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of WGSWW and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 4 added.

The largest buyer was UBS Group, adding an estimated $314. The largest seller was Ionic Capital Management, cutting an estimated $9.98K.

  • 21 institutional investors held GeneDx Holdings Warrant (WGSWW) as of Q4 2023, down from 22 in Q3 2023.
  • Funds reported $46.1K of GeneDx Holdings Warrant stock for Q4 2023, down 70% quarter-over-quarter.
  • 1 fund opened new GeneDx Holdings Warrant positions in Q4 2023 and 2 closed out, a net change of -1 holder.
  • The largest GeneDx Holdings Warrant buyer in Q4 2023 was UBS Group, an estimated $314 added.
  • The largest GeneDx Holdings Warrant seller in Q4 2023 was Ionic Capital Management, an estimated $9.98K sold.

Based on aggregated 13F filings for Q4 2023.